Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Sep 3, 2021
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2021-09-02$1.81/sh−61$110→ 15,260 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 09/01/2021.